199 related articles for article (PubMed ID: 11460570)
21. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus.
Blaak EE
Proc Nutr Soc; 2004 May; 63(2):323-30. PubMed ID: 15294050
[TBL] [Abstract][Full Text] [Related]
22. Ceramides in insulin resistance and lipotoxicity.
Summers SA
Prog Lipid Res; 2006 Jan; 45(1):42-72. PubMed ID: 16445986
[TBL] [Abstract][Full Text] [Related]
23. Reversible insulin resistance in non-insulin-dependent diabetes mellitus.
Karam JH
Horm Metab Res; 1996 Sep; 28(9):440-4. PubMed ID: 8911980
[TBL] [Abstract][Full Text] [Related]
24. Triglycerides, fatty acids and insulin resistance--hyperinsulinemia.
Kraegen EW; Cooney GJ; Ye J; Thompson AL
Exp Clin Endocrinol Diabetes; 2001; 109(4):S516-26. PubMed ID: 11453039
[TBL] [Abstract][Full Text] [Related]
25. Physiological and pathophysiological regulation of regional adipose tissue in the development of insulin resistance and type 2 diabetes.
Rattarasarn C
Acta Physiol (Oxf); 2006 Feb; 186(2):87-101. PubMed ID: 16497186
[TBL] [Abstract][Full Text] [Related]
26. Free fatty acids and skeletal muscle insulin resistance.
Rachek LI
Prog Mol Biol Transl Sci; 2014; 121():267-92. PubMed ID: 24373240
[TBL] [Abstract][Full Text] [Related]
27. Hypothesis: muscle insulin resistance is the ("not-so") thrifty genotype.
Reaven GM
Diabetologia; 1998 Apr; 41(4):482-4. PubMed ID: 9562354
[No Abstract] [Full Text] [Related]
28. Fat storage in pancreas and in insulin-sensitive tissues in pathogenesis of type 2 diabetes.
Assimacopoulos-Jeannet F
Int J Obes Relat Metab Disord; 2004 Dec; 28 Suppl 4():S53-7. PubMed ID: 15592487
[TBL] [Abstract][Full Text] [Related]
29. Insulin resistance: pathophysiology and rationale for treatment.
Muntoni S; Muntoni S
Ann Nutr Metab; 2011; 58(1):25-36. PubMed ID: 21304221
[TBL] [Abstract][Full Text] [Related]
30. Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity.
Poitout V; Robertson RP
Endocrinology; 2002 Feb; 143(2):339-42. PubMed ID: 11796484
[TBL] [Abstract][Full Text] [Related]
31. Lipid-induced insulin resistance: unravelling the mechanism.
Samuel VT; Petersen KF; Shulman GI
Lancet; 2010 Jun; 375(9733):2267-77. PubMed ID: 20609972
[TBL] [Abstract][Full Text] [Related]
32. [The pathogenesis of type 2 diabetes--new aspects and clinical consequences].
Donath MY; Maedler K; Sergeev P; Dyntar D; Thomas D; Spinas GA
Ther Umsch; 2002 Aug; 59(8):381-5. PubMed ID: 12235729
[TBL] [Abstract][Full Text] [Related]
33. The tail wagging the dog--regulation of lipid metabolism by protein kinase C.
Schmitz-Peiffer C
FEBS J; 2013 Nov; 280(21):5371-83. PubMed ID: 23587021
[TBL] [Abstract][Full Text] [Related]
34. Link between obesity and type 2 diabetes.
Golay A; Ybarra J
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):649-63. PubMed ID: 16311223
[TBL] [Abstract][Full Text] [Related]
35. Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?
Goodpaster BH; Kelley DE
Curr Diab Rep; 2002 Jun; 2(3):216-22. PubMed ID: 12643176
[TBL] [Abstract][Full Text] [Related]
36. [Role of skeletal muscle fat ectopic deposition in insulin resistance induced by high-fat diet].
Li T; Ruan DG; Gao JJ; Wang H; Xu XY
Sheng Li Xue Bao; 2018 Aug; 70(4):433-444. PubMed ID: 30112569
[TBL] [Abstract][Full Text] [Related]
37. Role of lipid-derived mediators in skeletal muscle insulin resistance.
Taube A; Eckardt K; Eckel J
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1004-12. PubMed ID: 19602581
[TBL] [Abstract][Full Text] [Related]
38. MECHANISMS IN ENDOCRINOLOGY: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?
Brøns C; Grunnet LG
Eur J Endocrinol; 2017 Feb; 176(2):R67-R78. PubMed ID: 27913612
[TBL] [Abstract][Full Text] [Related]
39. Role of lipids in insulin resistance and type 2 diabetes mellitus development.
Mingrone G; Castagneto M
Nutrition; 1999 Jan; 15(1):64-6. PubMed ID: 9918070
[No Abstract] [Full Text] [Related]
40. Pathophysiology of type 2 diabetes.
Scheen AJ
Acta Clin Belg; 2003; 58(6):335-41. PubMed ID: 15068125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
